Sign up to save your podcasts
Or
Share 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
View all episodes
By STAT
4.6
300300 ratings
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
More shows like The Readout Loud
View all
WSJ Tech News Briefing
1,642 Listeners
WSJ What’s News
4,323 Listeners
The Daily
111,539 Listeners
KFF Health News' 'What the Health?'
469 Listeners
The Long Run with Luke Timmerman
117 Listeners
The Journal.
5,892 Listeners
Morning Brew Daily
2,935 Listeners
Tradeoffs
391 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
84 Listeners
BioCentury This Week
31 Listeners
Raising Health
141 Listeners
Biotech Hangout
9 Listeners
ACQ2 by Acquired
190 Listeners
Ground Truths
42 Listeners